Sales of Johnson & Johnson's pharmaceutical products 2020-2022

Johnson and Johnson is a major international pharmaceutical company. In 2022, among its top pharmaceutical drugs was Remicade which earned some 2.3 billion U.S. dollars in sales for the company. Remicade is a drug used in the treatment of Crohn’s disease and ulcerative colitis. The highest revenue generating drug at that time was Stelara which generated 9.7 billion U.S. dollars in revenue for the company.

International pharmaceutical companies

There are several major pharmaceutical companies that are making significant economic impacts globally. In 2021, Pfizer, Novartis, and AbbVie were the top pharmaceutical companies based on their prescription drug sales globally. Despite being excluded from the top three list of pharmaceutical companies based on prescription drug sales, Johnson and Johnson is among the top four drug companies based on drug sales. However, when viewed by market capitalization, Johnson and Johnson was the top global pharmaceutical company.

Top pharmaceuticals

The global pharmaceutical industry has never generated as much revenue as it has in recent years. Globally, oncologics, antidiabetics and respiratory drug classes are among the very top classes based on total sales. However, there are some drugs that are more widely distributed and sold globally. In 2021, when covid vaccines are excluded, Humira from AbbVie, Keytruda from Merck & Co. and Revlimid by BMS were the top drugs based on sales worldwide.